TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Repolar Pharmaceuticals Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
8,687
|
8,154
|
8,397 |
Financial expenses |
10
|
0 | |
Earnings before taxes |
800
|
10
|
0 |
Total assets |
5,515
|
5,018
|
4,615 |
Current assets |
1,163
|
803
|
4,253 |
Current liabilities |
927
|
851
|
679 |
Equity capital |
4,598
|
4,168
|
3,936 |
- share capital |
482
|
507
|
480 |
Employees (average) |
6
|
4
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
83.4%
|
83.1%
|
85.3% |
Turnover per employee |
1,448
|
2,038
|
1,679 |
Profit as a percentage of turnover |
9.2%
|
0.1%
|
0% |
Return on assets (ROA) |
0.4%
|
0% | |
Current ratio |
125.5%
|
94.4%
|
626.4% |
Return on equity (ROE) |
17.4%
|
0.2%
|
0% |
Change turnover |
936
|
-717 | |
Change turnover % |
12%
|
-8% | |
Chg. No. of employees |
2
|
-1 | |
Chg. No. of employees % |
50%
|
-20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.